Literature DB >> 10815993

In vitro biological activities of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with N-acetylneuraminic acid.

K Moriya1, T Chiba, S Nabeshima, H Hayashi, K Onozaki.   

Abstract

In the previous study, N-acetylneuraminic acid (NANA) with C9 spacer was chemically coupled to human recombinant (rh) IL-1alpha in order to study the effect of glycosylation on its biological activities, and to develop IL-1 with less deleterious effects. In this study we examined a variety of IL-1 activities in vitro, including proliferative effect on T cells, antiproliferative effect on myeloid leukemic cells and melanoma cells, stimulatory effects on IL-6 synthesis by melanoma cells and PGE2 synthesis by fibroblast cells. NANA-introduced IL-1alpha (NANA-IL-1alpha) exhibited reduced activities about ten times compared with original IL-1alpha in all the activities performed in vitro. The competitive binding of 125I-IL-1alpha to mouse T cells and pre-B cells with unlabeled IL-1alphas suggests the decrease in binding affinities of NANA-IL-1alpha to both type I and type II IL-1 receptors. Therefore, reduced activities of NANA-IL-1alpha well correlated with the decrease in its receptor binding affinities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10815993     DOI: 10.1023/a:1007082207188

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  32 in total

1.  Glycosylation of the human interferon-gamma receptor. N-linked carbohydrates contribute to structural heterogeneity and are required for ligand binding.

Authors:  T Fischer; B Thoma; P Scheurich; K Pfizenmaier
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

2.  Simple, sensitive and specific bioassay of interleukin-1.

Authors:  S J Hopkins; M Humphreys
Journal:  J Immunol Methods       Date:  1989-06-21       Impact factor: 2.303

3.  Purification and physico-chemical characterization of rabbit tumor necrosis factor.

Authors:  M R Ruff; G E Gifford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  D-mannose dimer introduced human recombinant interleukin- 1 alpha, NEO IL-1 alpha, exhibits altered tissue distribution in mice.

Authors:  Y Takei; T Chiba; S Nabeshima; M Naruoka; K Wada; K Onozaki
Journal:  J Interferon Cytokine Res       Date:  1996-04       Impact factor: 2.607

5.  Production of recombinant mouse beta-interferon.

Authors:  T Tanaka; M Naruto; G Kawano
Journal:  J Interferon Res       Date:  1986-08

6.  Development of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with D-galactose monosaccharide: biological activities in vivo.

Authors:  S Nabeshima; T Chiba; Y Takei; A Ono; K Moriya; K Onozaki
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

7.  Glycosylated human recombinant interleukin-1 alpha, neo interleukin-1 alpha, with D-mannose dimer exhibits selective activities in vivo.

Authors:  Y Takei; T Chiba; K Wada; H Hayashi; M Yamada; J Kuwashima; K Onozaki
Journal:  J Interferon Cytokine Res       Date:  1995-08       Impact factor: 2.607

8.  Glycosylation of the interleukin-1 receptor type I is required for optimal binding of interleukin-1.

Authors:  J Mancilla; T Ikejima; C A Dinarello
Journal:  Lymphokine Cytokine Res       Date:  1992-08

9.  Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1.

Authors:  K Onozaki; T Tamatani; T Hashimoto; K Matsushima
Journal:  Cancer Res       Date:  1987-05-01       Impact factor: 12.701

10.  Binding site of the rabbit liver lectin specific for galactose/N-acetylgalactosamine.

Authors:  R T Lee
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

View more
  3 in total

1.  Synthesis and biological activities in vitro and in vivo of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with N -acetylneuraminyl-galactose.

Authors:  Masaaki Ootsubo; Taku Chiba; Yutaka Kobayashi; Hidetoshi Hayashi; Akiko Hayashi; Kikuo Onozaki
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  N-acetylneuraminic acid coupled human recombinant TNFalpha exhibits enhanced anti-tumor activity against Meth-A fibrosarcoma and reduced toxicity.

Authors:  Akiko Hayashi; Hidetoshi Hayashi; Taku Chiba; Satoshi Sasayama; Kikuo Onozaki
Journal:  Cancer Immunol Immunother       Date:  2006-10-10       Impact factor: 6.968

3.  Glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with N-acetylneuraminic acid exhibits selective activities in vivo and altered tissue distribution.

Authors:  S Sasayama; K Moriya; T Chiba; T Matsumura; H Hayashi; A Hayashi; K Onozaki
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.